We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Honeywell
HON
$76.4B
| $163M | 0.36% |
1,311,863
-47,529
| -3% | -$6.49M |
|
52
NextEra Energy
NEE
$185B
| $163M | 0.35% |
3,741,732
+143,368
| +4% | +$6.27M |
|
|
53
CVS Health
CVS
$135B
| $162M | 0.35% |
2,474,797
+519,488
| +27% | +$38.8M |
|
54
Costco
COST
$432B
| $158M | 0.34% |
775,087
+1,748
| +0.2% | +$390K |
|
55
Accenture
ACN
$106B
| $154M | 0.33% |
1,091,024
-4,304
| -0.4% | -$681K |
|
56
RTX Corp
RTX
$290B
| $148M | 0.32% |
2,212,366
+211,222
| +11% | +$16.6M |
|
57
Thermo Fisher Scientific
TMO
$214B
| $146M | 0.32% |
652,036
+7,916
| +1% | +$1.86M |
|
58
Starbucks
SBUX
$119B
| $145M | 0.32% |
2,252,733
-159,455
| -7% | -$9.98M |
|
59
Altria Group
MO
$125B
| $142M | 0.31% |
2,881,671
-4,358
| -0.2% | -$253K |
|
60
NVIDIA
NVDA
$4.6T
| $139M | 0.3% |
41,645,680
-61,840
| -0.1% | -$296K |
|
61
Bristol-Myers Squibb
BMY
$129B
| $137M | 0.3% |
2,642,273
+9,171
| +0.3% | +$493K |
|
62
Booking.com
BKNG
$156B
| $137M | 0.3% |
1,992,825
-19,800
| -1% | -$1.45M |
|
|
63
Cigna
CI
$78.4B
| $135M | 0.29% |
711,239
+258,714
| +57% | +$54M |
|
64
Elevance Health
ELV
$81.5B
| $135M | 0.29% |
513,110
+11,270
| +2% | +$3.1M |
|
65
ConocoPhillips
COP
$144B
| $134M | 0.29% |
2,152,694
+12,664
| +0.6% | +$862K |
|
66
American Tower
AMT
$83.5B
| $133M | 0.29% |
839,081
+9,939
| +1% | +$1.55M |
|
67
US Bancorp
USB
$97.9B
| $131M | 0.29% |
2,866,549
+1,701
| +0.1% | +$87.6K |
|
68
Gilead Sciences
GILD
$165B
| $131M | 0.28% |
2,086,663
+1,919
| +0.1% | +$134K |
|
69
CME Group
CME
$95.4B
| $130M | 0.28% |
692,993
+34,206
| +5% | +$6.32M |
|
70
Lowe's Companies
LOW
$121B
| $130M | 0.28% |
1,408,140
-3,492
| -0.2% | -$337K |
|
|
71
Linde
LIN
$236B
| $126M | 0.27% |
+805,738
| New | +$127M |
|
72
Qualcomm
QCOM
$164B
| $122M | 0.27% |
2,144,645
-343,743
| -14% | -$20.9M |
|
73
American Express
AXP
$224B
| $119M | 0.26% |
1,252,985
+366
| +0% | +$38.3K |
|
74
Danaher
DHR
$138B
| $115M | 0.25% |
1,261,516
+15,876
| +1% | +$1.44M |
|
75
Caterpillar
CAT
$361B
| $111M | 0.24% |
873,834
-25,057
| -3% | -$3.26M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.